Hesham A Abou-Zied

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Endoplasmic Reticulum Stress

Advanced Non Small Cell Lung Cancer

Molecular Docking

Top Venues

Pharmaceuticals (Basel, Switzerland)

Archiv der Pharmazie

International journal of molecular sciences

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Lamya H Al-Wahaibi, Hesham A Abou-Zied, Mohamed Hisham, Eman A M Beshr, Bahaa G M Youssif, Stefan Bräse, Alaa M Hayallah, Mohamed Abdel-Aziz
Design, Synthesis, and Biological Evaluation of Novel 3-Cyanopyridone/Pyrazoline Hybrids as Potential Apoptotic Antiproliferative Agents Targeting EGFR/BRAF V600E Inhibitory Pathways. Molecules (Basel, Switzerland) 28 (18) (2023)
Lamya H Al-Wahaibi, Hesham A Abou-Zied, Eman A M Beshr, Bahaa G M Youssif, Alaa M Hayallah, Mohamed Abdel-Aziz
Design, Synthesis, Antiproliferative Actions, and DFT Studies of New Bis-Pyrazoline Derivatives as Dual EGFR/BRAF V600E Inhibitors. International journal of molecular sciences 24 (10) (2023)
Lamya H Al-Wahaibi, Mohamed Hisham, Hesham A Abou-Zied, Heba A Hassan, Bahaa G M Youssif, Stefan Bräse, Alaa M Hayallah, Mohamed Abdel-Aziz
Quinazolin-4-one/3-cyanopyridin-2-one Hybrids as Dual Inhibitors of EGFR and BRAF V600E : Design, Synthesis, and Antiproliferative Activity. Pharmaceuticals (Basel, Switzerland) 16 (11) (2023)
Hesham A Abou-Zied, Eman A M Beshr, Hesham A M Gomaa, Yaser A Mostafa, Bahaa G M Youssif, Alaa M Hayallah, Mohamad Abdel-Aziz
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAF V600E with promising antiproliferative properties. Archiv der Pharmazie (2022)